National Business Group on Health
Key 2020 Strategies for Health Care Costs
While growth in health costs stays flat, companies are employing more virtual care, innovating primary care, and seeking solutions to specialty drug costs.
House to Vote for Repeal of ACA’s ‘Cadillac Tax’
Despite strong bipartisan support for a repeal of the onerous excise tax on health benefits, its fate in the Senate remains unclear.
Do Companies Get Their Money’s Worth from ‘Wellness’?
Many companies plan to continue or expand financial incentives over the next three to five years; however, the effects of such programs are largely unknown.
5 Health Care Trends for CFOs to Watch in 2019
With companies still pressured by rising health benefits costs, they must actively engage in taking advantage of systemic changes in the health care market.
How Will Insurer-PBM Deals Affect Health Costs?
It may take awhile, but the recent mergers of health insurers and pharmacy benefits managers could meaningfully mitigate the costs of care.
Companies Plead for New Pharma Supply Model
The long-entrenched system of drug-manufacturer rebates has not adapted to changes in health-plan designs and labor-market trends.
After Another Cadillac Tax Delay, Now What?
With the tax perhaps unlikely to ever take effect, should companies still factor it into their benefits planning and strategies?
Plan-Design Changes Have Less Impact on Health Costs
Employers expect to cut way back next year on shifting health costs to their workers.
Senate Health Bill Wins Corporate Favor
While millions would become uninsured if the bill became law, group health plans would mostly benefit, observers say.
As core strategies for containing employee health-care costs diminish in effectiveness, companies need fresher approaches.
How to Rein In the Soaring Costs of Specialty Drugs
The 420-employer National Business Group on Health recommends public-policy changes relating to the proliferating category of specialty drugs.